John Overdeck’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,600
Closed -$1.05M 3217
2019
Q4
$1.05M Buy
9,600
+800
+9% +$81K ﹤0.01% 2137
2019
Q3
$803K Buy
8,800
+3,000
+52% +$273K ﹤0.01% 2170
2019
Q2
$566K Buy
+5,800
New +$565K ﹤0.01% 2401
2019
Q1
Sell
-10,700
Closed -$873K 3091
2018
Q4
$873K Buy
+10,700
New +$972K ﹤0.01% 1734
2017
Q1
Sell
-2,900
Closed -$251K 2960
2016
Q4
$251K Buy
+2,900
New +$259K ﹤0.01% 2833
2016
Q3
Sell
-6,000
Closed -$639K 3139
2016
Q2
$639K Buy
+6,000
New +$619K ﹤0.01% 2076
2016
Q1
Sell
-14,000
Closed -$1.25M 2844
2015
Q4
$1.25M Buy
14,000
+7,000
+100% +$625K 0.01% 1356
2015
Q3
$634K Buy
+7,000
New +$701K ﹤0.01% 1428

Other funds holding CRI

John Overdeck's CRI Position: Q2 2026 in Review

John Overdeck increased its Carter's (CRI) stake by 201% in Q2 2026, buying an estimated $9.15M and bringing the position to 362,068 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #1230.

John Overdeck first reported a position in CRI in Q2 2013 and has held it in 20 quarters since. The position peaked at $44M in Q1 2016. 285 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • John Overdeck held 362,068 shares of Carter's worth $14.9M as of Q2 2026.
  • John Overdeck bought 241,867 Carter's shares in Q2 2026, an estimated $9.15M.
  • Carter's made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1230 holding.
  • John Overdeck first reported a position in Carter's in Q2 2013 and has held it in 20 quarters since.
  • John Overdeck's Carter's position peaked at $44M in Q1 2016.
  • 285 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.